期刊文献+

pIRES-IL-24对Bel-7402肝癌细胞抑制的实验研究

Inhibition effect of pIRES-IL-24 on Bel-7402 cells
原文传递
导出
摘要 目的:观察白细胞介素-24(IL-24)基因对肝癌细胞系Bel-7402生长的抑制作用,为肝癌的基因治疗提供理论基础。方法:将真核分泌表达载体pIRES-IL-24转染肝癌细胞系Bel-7402。RT-PCR检测IL-24基因的表达,蛋白质印迹法及ELISA检测IL-24蛋白的表达,MTT法检测IL-24对肝癌细胞的生长抑制和杀伤作用,流式细胞仪检测细胞的凋亡和细胞周期。结果:pIRES-IL-24能够在Bel-7402中高效表达。细胞培养上清液中IL-24蛋白表达浓度为124.1 ng/mL。IL-24能明显抑制Bel-7402肝癌细胞的生长,转染后第4天抑制率为46.3%,与对照组比较,P<0.05。IL-24促进肝癌细胞的凋亡,凋亡率41.0%,与对照组比较,P<0.05。细胞周期分析显示,IL-24阻滞肝癌细胞在G2/M期。结论:重组表达载体pIRES-IL-24介导IL-24基因在人肝癌细胞中高效表达,可杀伤肝癌细胞Bel-7402,促进细胞增殖阻滞及诱导肿瘤细胞凋亡。 OBJECTIVE:To investigate the inhibitory effect and anti-cancer mechanism of pIRES-IL-24 mediated IL-24 gene on hepatocarcinoma Bel-7402 cells and gene therapy of liver cancer theory.METHODS: The eukaryotic expression vector pIRES-IL-24 was transfected into hepatoma cell line Bel-7402.IL-24 gene expression was detected by RT-PCR,IL-24 protein expression was detected by Western and ELISA.IL-24 was assayed with MTT on hepatoma cell growth inhibition and cytotoxicity.The apoptosis and cell cycle were detected with FCM(flow cytometry).RESULTS: pIRES-IL-24 efficiently expressed in Bel-7402 cells.In cell culture supernatant,IL-24 protein expression was detected,the concentration of IL-24 protein was 124.1 ng/mL.And IL-24 inhibited the Bel-7402 liver cancer cell growth.On the fourth day after transfection,the inhibition rate was 46.3% compared with the control group(P0.05).IL-24 for liver cancer cell apoptosis,the apoptosis rate was 41.0%,compared with the control group,(P0.05).The cell cycle analysis showed that liver IL-24 and block cancer cells were in G2/M phase.CONCLUSION: Recombinant expression vector pIRES-IL-24 mediated IL-24 gene is highly expressed in human liver cancer cells,and it could kill liver cancer cells Bel-7402,promote cell proliferation arrest and induce tumor cell apoptosis.
出处 《中华肿瘤防治杂志》 CAS 2010年第23期1912-1915,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 山东省自然科学基金(Y2007C150)
关键词 肝肿瘤/病理学 白细胞介素类 细胞凋亡 liver neoplasms/patholgy interleukins apoptosis
  • 相关文献

参考文献13

  • 1Jiang H, Lin J J, Su Z Z, et al. Subtraction hybridization dentilies a novel melanoma differentiation assciated gene, med-7, modulated during human melanoma ifferentiation, growth and progression[J]. Oncogene, 1995,11(12):2477-2486.
  • 2Caudell E G, Mumm J B, Poindexter N, et al. The protein product of the tumor suppressor gene, melanoma differentiation assciated gene 7, exhibits immunostimulatory activity and is designated IL24[J]. J Immunol, 2002, 168(12): 6041-6046.
  • 3Lebdeva I V, Emdad L, Su Z Z, et al. Mda-7/IL-24, novel anti- cancer cytokine: Fcus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase 1 clinical experience[J]. Int J Oncol, 2007, 31(5) ~ 985 1007.
  • 4Huang E Y, Madireddi M T, Fisher P B, et al. Genomic structure, chromosomal lcalization and expression profile of a novel melanoma differentiation assciated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties [J]. Oncogene, 2001, 20(48):7051-7063.
  • 5孟刚,张扬,蔺勇,王广义.MT1-MMP对人肝癌细胞株HepG2生物学行为的影响[J].中国老年学杂志,2009,29(2):198-199. 被引量:2
  • 6Lebedeva I V, Su Z Z, Sarkar D, et al. Restoring apoptosis as a strategy for cancer gene therapy= focus on p53 and mda-7[J]. Semin Cancer Biol, 2003, 13:169-178.
  • 7Nagalakshmi M L, Murphy E, McClanahan T, et al. Expression patterns of IL10 ligand and receptor gene families provide leads for biological charaeterization[J]. Int Immunopharmacol, 2004, 4: 577- 592.
  • 8Yah S, Xie X F, Yang J C, et al. Study of effects of rhIL 24on the growth gastric cancer cell line in vitro and itsmechanism[J]. Suzhou University J Med Sci, 2006, 26(3) :370-374.
  • 9Nishikawa T, Ramesh R, Munshi A, et al. Adenovirus mediated mda- 7(IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation[J]. Mol Ther,2004, 9(6) :818-828.
  • 10Yu R T, Chen R, Tang H, et al. Hammerhead ribozyme targeting human hypoxia inducible factor-1a geneeffectively attenuates HeLa xenograft tumors[J]. Surg Neurol, 2008, 7(3): 56-65.

二级参考文献14

  • 1Yang, Yong-Jiu,Chen, Da-Zhi,Li, Li-Xin,Sheng, Qin-Song,Jin, Zhong-Kui,Zhao, De-Fang.Targeted IL-24 gene therapy inhibits cancer recurrence after liver tumor resection by inducing tumor cell apoptosis in nude mice[J].Hepatobiliary & Pancreatic Diseases International,2009,8(2):174-178. 被引量:5
  • 2Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion [J]. Cancer Lett, 2003 ; 194 ( 1 ) : 1-11.
  • 3Sato H, Okada Y, Seiki IVL Membrane type-I matrix metalloproteinase(MTMMPs) in cell invasion[J]. Thromb Haemost,1997;78( 1 ) :497-500.
  • 4Blanc JF, Bisson C, Frankenne F, et al. Hepatocarcinoma cell lines down-regulate matrix metalloproteinase-2 expression in human hepatic myofibroblasts [ J ]. Int J Oncol,2002 ;20 ( 6 ) :1129-36.
  • 5Sodek KL,Ringuette MJ ,Brown TJ. MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells [ J ]. Br J Cancer,2007 ;97 (3) :358-67.
  • 6Petrella BL,Brinckerhoff CE. Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinase[J]. Mol Cancer,2006;5:66.
  • 7Jiang WG, Davies G, Martin TA,et al. Expression of membrane type-I matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells[J]. Int J Mol Med,2006;17 (4) :583-90.
  • 8Knauper V, Lopez-Otin C, Smith B,et al. Biochemical characterization of human collagenase-3 [J]. J Biol Chem, 1996 ;271 (3) : 1544-50.
  • 9Baciu PC, Suleiman EA, Deryugina El, et al. Membrane type-I matrix metallopmteinase(MT1-MMP) processing of proalphav integrin regulates crosstalk between alphavbeta3 and alpha2betal integrins in breast carcinoma cells[J]. Exp Cell Res,2003 ;291 ( 1 ) : 167-75.
  • 10Kajita M,Itoh Y,Chiba T,et al. Membrane type-I matrix metalloproteinase cleaves CD44 and promotes cell migration[J]. J Cell Bio1,2001 ;153 ( 5 ) : 893-904.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部